Search Results 1151-1160 of 18469 for Prednisone

1. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Receiving chronic systemic steroid therapy (in doses exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 14 ...

2. Polymyalgia rheumatica - Symptoms & causes - Mayo Clinic

   Older adults who get sudden muscle pain and stiffness, mainly in the shoulders, might have this condition.

3. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

   contrast, intermittent corticosteroid use (e.g., daily prednisone at doses of ≤10 mg or equivalent), bronchodilators, inhaled steroids, or local steroid ...

4. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy

   Candidates may not be taking prednisone, cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, anti-lymphocyte agents, cyclophosphamide ...

5. Trospium (oral route) - Side effects & dosage - Mayo Clinic

   However, elderly patients are more likely to have some unwanted effects (eg, constipation, dry mouth, indigestion, stomach pain, or trouble passing urine) which ...

6. Publications - Irina Bancos, M.D., M.S. - Mayo Clinic

   Impact of hydrocortisone vs prednisone therapy on postsurgical recovery in patients with endogenous hypercortisolism: a prospective cohort study. Eur J ...

7. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   ... prednisone for at least 1 month prior to first dose of study treatment; low dose steroid use for the control of nausea and vomiting will be allowed; topical ...

8. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   Participation eligibility · Clinically significant active infection. · Current or expected need for daily systemic corticosteroid therapy ≥ 10 mg of prednisone ...

9. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

   Persons requiring systemic corticosteroids (>10 mg prednisone or equivalent per day) and/or other immunosuppressive therapy. Patients are allowed to use ...

10. Dorzolamide (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Dorzolamide ophthalmic (eye) drops is used to treat increased pressure in the eye caused by open-angle glaucoma or a condition called hypertension of the eye.